Allogeneic processed thymus tissue (Enzyvant )

N/A

Report date: 2024/01/25 11:03:19

Base Information

Drug NameAllogeneic processed thymus tissue (Enzyvant )
Drug Alias Namethymus tissue based therapyAllogeneic processed thymus tissue–agdcRETHYMICRVT-802IND-9836
ClassificationCell and gene therapy > Cell therapy > Donor > Allogeneic
Mechanisms of ActionTissue replacementsCell replacements
TargetsNot applicable
Therapy Area/IndicationsDiGeorge Syndrome
Global Approved IndicationsDiGeorge Syndrome
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2021/10/08
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesDuke University
China Registration ClassN/A

Develop Information

Active CompaniesEnzyvant Therapeutics GmbhSumitomo Pharmaceuticals (Suzhou) Co Ltd
Inactive CompaniesEnzyvant
Active IndicationsDiGeorge Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A